Reduction of hydroxamic acids to the corresponding amides catalyzed by rabbit blood

References

• ALLABEN, W. T., WEEKA, C. E., WEIS, C. C., BURGER, G. T. and KING, C. M., 1982, Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acy1-2-aminofluorene: relationship to metabolic activation. Carcinogenesis, 3, 233–240.
   Google Scholar
• BERNHEIM, M. L., 1965, Metabolism of anthranilic hydroxamic acid by rat liver. Archives of Biochemistry Biophysics, 112, 191–195.
   Google Scholar
• BERNHEIM, M. L., 1972, The reduction of hydroxylamine and some arylhydroxamates by liver mitochondria from mammals and birds. Enzymologia, 43, 167–176.
   PubMedGoogle Scholar
• BICKEL, M. H., WEDER, H. J. and AEBI, H., 1968, Metabolic interconversions between imipramine, its N-oxide, and its desmethyl derivative in rat tissues in vitro. Biochemical and Biophysical Research Communications, 33, 1012–1018.
   PubMed Web of Science ®Google Scholar
• CALDER, I. C., Goss, D. E., WILLIAMS, P. J., FUNDER, C. C., GREEN, C. R., HAM, K. N. and TANGE, J. D.,1976, Neoplasia in the rat induced by N-hydroxyphenacetin, a metabolite of phenacetin. Pathology, 8, 1–6.
   PubMed Web of Science ®Google Scholar
• CLEMENT, B. and DEMESMAEKER, M., 1997, Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2. Drug Metabolism and Disposition, 25, 1266–1271.
   PubMed Web of Science ®Google Scholar
• CLEMENT, B. and JUNG, F., 1994, N-Hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Drug Metabolism and Disposition, 22, 486–497.
   PubMed Web of Science ®Google Scholar
• CLEMENT, B., SCHULTZE -MOSGAU, M. H., RICHTER, PH. and BESCH, A., 1994, Cytochrome P450-dependent N-hydroxylation of an aminoguanidine (amidinohydrazone) and microsomal retro-reduction of the N-hydroxylated product. Xenobiotica, 24, 671–688.
   Google Scholar
• CLEMENT, B., SCHULTZE -MOSGAU, M. H. and WOHLERS, H., 1993, Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Biochemical Phar-macology, 46, 2249–2267.
   Google Scholar
• CORBETT, M. D., WEI, C. L., FERNANDO, S. Y., DOERGO, D. R. and CORBETT, B. R., 1983, The synthesis and mutagenicity of N-formyl analog of N-hydroxyphenacetin. Carcinogenesis, 4, 1615–1618.
   Google Scholar
• CRAMER, J. W., MILLER, j. A. and MILLER, E. C., 1960, N-Hydroxylation: a new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluorene. Journal of Biological Chemistry, 235, 885–888.
   PubMed Web of Science ®Google Scholar
• DYBING, E., SAXHOLM, H. J., AUNE, T., WIRTH, P. J. and THORGEIRSSON, S. S., 1981, Studies on mutagenic and carcinogenic N-substituted aryl compounds: cosmetics and drugs. National Cancer Institute Monographs, 58, 21–26.
   Google Scholar
• GRANTHAM, P. H., HORTON, R. E., WEISBURGER, E. K. and WEISBURGER, J. H., 1970, Metabolism of the carcinogen N-hydroxy-N-2 -fluorenylacetamide in germ-free and conventional rats. Biochemical Pharmacology, 19, 163–171.
   PubMed Web of Science ®Google Scholar
• GRANTHAM, P. H., WEISBURGER, E. K. and WEISBURGER, J. H., 1965, Dehydroxylation and deacetylation of N-hydroxy-N-2-fluorenylacetamide by rat liver and brain homogenates. Biochimica et Biophysica Acta, 107, 414–424.
   PubMed Web of Science ®Google Scholar
• GRIFFITH, D. P., GIBSON, J. R., CLINTON, C. W. and MUSHER, D. M., 1978, Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghom renal calculi. Journal Urology. 119, 9–15.
   PubMed Web of Science ®Google Scholar
• GUTVIANN, H. R. and ERICKSON, R. R., 1969, The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amindophenols by rat liver in vitro. Journal of Biological Chemistry, 244, 1729–1740.
   Google Scholar
• HINSON, J. A. and MITCHELL, J. A., 1976, N-Hydroxylation of phenacetin by hamster liver microsomes. Drug Metabolism and Disposition, 4, 430–435.
   PubMed Web of Science ®Google Scholar
• HIRSCH, P. F. and KAPLAN, N. O., 1961, The conversion of pyridine hydroxamic acids to amides by mouse liver mitochondria. Journal of Biological Chemistry, 236, 926–930.
   PubMed Web of Science ®Google Scholar
• IRVING, C. C., 1962, N-Hydroxylation of 2-acetylaminofluorene in the rabbit. Cancer Research, 22, 867–873.
   Web of Science ®Google Scholar
• IRVING, C. C., 1964, Enzymatic N-hydroxylation of the carcinogen 2-acetylaminofluorene and the metabolism of N-hydroxy-2 -acetylaminofluorene -9-14C in vitro. Journal of Biological Chemistry, 239, 1589–1596.
   PubMed Web of Science ®Google Scholar
• JOHANSSON, S. L., 1981, Carcinogenicity of analgesics: long-term treatment of Sprague—Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetamidophen). International Journal of Cancer. 27, 521–529.
   PubMed Web of Science ®Google Scholar
• KATSURA, H., KTTAMURA, S. and TATSUMI, K., 1993, Purification and characterization of salicyl-hydroxamic acid reductase from rat liver. Archives of Biochemistry and Biophysics, 302, 356–361.
   Google Scholar
• KIESE, M., RENNER, G. and SCHLAEGE R., 1971, Mechanism of the autocatalytic formation of ferrihemoglobin by N, N-dimethylaniline N-oxide. Naunyn—Schmiedebergs Archives of Phar-macology, 268, 247–263.
   PubMedGoogle Scholar
• KTTAMURA S., KUWASAKO, M., SUGIHARA, K. and TATSUMI, K., 1999a, Debromination of a-(bromo-iso-valeryl)urea catalyzed by rat blood. Journal of Pharmacy and Pharmacology, 51, 73–78.
   Google Scholar
• KTTAMURA S., SUGIHARA, K. and TATSUMI, K., 1994, Reductase activity of aldehyde oxidase toward the carcinogenN-hydroxy-2-acetylaminofluorene and the related hydroxamic acids. Biochemistry and Molecular Biology International, 34, 1197–1203.
   Google Scholar
• KTTAMURA S., SUGIHARA, K. and TATSUMI, K., 1999b, A unique tertiary amine N-oxides reduction system composed of quinone reductase and heme in rat liver preparations. Drug Metabolism and Disposition, 27, 92–97.
   Google Scholar
• KTTAMURA S., TAKEKAWA., K., SUGIHARA, K., TAThumi, K. and OHTA, S., 1999c, Pseudoenzymatic reduction of N-hydroxy-2-acetylaminofluorene to 2 -acetylaminofiuorene mediated by cyto - chrome P450. Carcinogenesis, 20, 347–350.
   Google Scholar
• KTTAMURA, S. and TATSUMI, K., 1985, Purification of N-hydroxy-2-acetylaminofluorene reductase from rabbit liver cytosol. Biochemical and Biophysical Research Communications, 133, 67–74.
   Google Scholar
• KTTAMURA S., TERADA, A., INovE, N., KAMIO, H., OHTA, S. and TATSUMI, K., 1998, Quinone-dependent tertiary amine N-oxide reduction in rat blood. Biological and Pharmaceutical Bulletin, 21, 1344–1347.
   Google Scholar
• LENK, W. and SCHARMER, U., 1980, Reaction of microsomal and cytosolic enzymes with N-arylacetohydro xamic acids. Xenobiotica, 10, 573–591.
   PubMed Web of Science ®Google Scholar
• LOTLIKAR, P. D., MILLER, E. C., MILLER, J. A. and MARGRETH, A., 1965, The enzymatic reduction of the N-hydroxy derivatives of 2-acetylaminofluorene and related carcinogens by tissue preparations. Cancer Research, 25, 1743–1752.
   PubMed Web of Science ®Google Scholar
• LOWENTHAL, J., 1954, Enzymatic conversion of salicylhydroxamic acid to salicylamide. Nature (London), 174, 36–37.
   Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MILLER, J. A., 1970, Carcinogenesis by chemicals: an overview. G. H. A. Clowes Memorial Lecture. Cancer Research, 30, 559–576.
   PubMed Web of Science ®Google Scholar
• MILLER, J. A., CRAMER, J. W. and MILLER, E. C., 1960, The N- and ring-hydroxylation of 2-acetylaminofiuorene during carcinogenesis in the rat. Cancer Research, 20, 950–962.
   PubMed Web of Science ®Google Scholar
• MUNSON, J. W., 1982, Chemistry and biology of hydroxamic acids—an overview. In H. Kehl (ed.), Chemistry and Biology of Hydroxamic Acids (New York: Karger), pp. 1–13.
   Google Scholar
• NERY, R., 1971, The possible role of N-hydroxylation in the biological effects of phenacetin. Xenobiotica, 1, 339–343.
   PubMedGoogle Scholar
• Pows, G. and DE GRAW, C. L., 1980, N-Oxide reduction by hemoglobin, cytochrome c and ferrous ions. Research Communications Chemical Pathology and Pharmacology, 30, 143–150.
   Google Scholar
• PUTCHA, L., Giu(Frr0, D. P. and FELDMAN, S., 1984, Disposition of 14C-acetohydroxamic acid and 14C-acetamide in the rat. Drug Metabolism and Disposition, 12, 438–443.
   Google Scholar
• SINGER, T. P. and KEARNEY, F. B., 1950, The non-enzymatic reduction of cytochrome c by pyridine nucleotides and its catalysis by various fiavins. Journal of Biological Chemistry, 183, 409–429.
   Google Scholar
• SUGIHARA, K., KTTAMURA, S. and OitrA, S., 1998, Reductive dechlorination of DDT to DDD by rat blood. Biochemistry and Molecular Biology International, 45, 85–91.
   PubMedGoogle Scholar
• SUGIHARA, K., KITAMURA, S. and TAISUMI, K., 1983, Evidence for reduction of hydroxamic acids to the corresponding amides by liver aldehyde oxidase. Chemical and Pharmaceutical Bulletin, 31, 3366–3369.
   PubMed Web of Science ®Google Scholar
• SUGIHARA, K. and TAThumi, K., 1986, Participation of liver aldehyde oxidase in reductive metabolism of hydroxamic acids to amides. Archives of Biochemistry and Biophysics, 247, 289–293.
   PubMed Web of Science ®Google Scholar
• TERAYAMA, H., 1963 Aminoazo dye amine-N-oxide as a possible intermediate metabolite preceding N-demethylation and ortho-hydroxylation, as well as azo dye—protein binding. Gann, 55, 195–204.
   Google Scholar
• VAISEY, E. B., 1956, The non-enzymic reduction of trimethylamine oxide to trirnethylamine, dirnethyl-amine, and formaldehyde. Canadian Journal of Biochemistry and Physiology, 34, 1085–1090.
   PubMedGoogle Scholar
• WEEKS, C. E., ALLABEN, W. T., TRESP, N. M., LOUIE, S. C., LAZEAR, E. J. and KING, C. M., 1980, Effect of structure of N-acyl-N-2 -fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538. Cancer Research, 40, 1204–1211.
   Google Scholar
• WEISBURGER, J. H., GRANTHAM, P. H., HORTON, R. E. and WEISBURGER, E. K., 1970, Metabolism of the carcinogen N-hydroxy-N-2-fluorenylacetamide in germ-free rats. Biochemical Pharmacology, 19, 151–162.
   PubMed Web of Science ®Google Scholar
• WILLIAMS, J. R., GRANTHAM, P. H., MARSH, H. H., WEISBURGER, J. H. and WEISBURGER, E. K., 1970, Participation of liver fractions and of intestinal bacteria in the metabolism of N-hydroxy-N-2-fluorenylacetamide in the rat. Biochemical Pharmacology 19, 173–188.
   PubMed Web of Science ®Google Scholar
• WIRTH, P. J., ALEWOOD, P., CALDER, I. and THORGEIRSSON, S. S., 1982, Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR. Carcinogenesis, 3, 167–170.
   Google Scholar
• YAMAZOE, Y., Ism", K., YAMAGUCHI, N., KAMATAKI, T. and KATO, R., 1980, Reduction of N-hydroxy-2 -acetylaminofluorene by liver microsomes. Biochemical Pharmacology, 29, 2183–2188.
   Google Scholar
• YUBISUI, T., MAISUKI, T., TANISHIMA, K., TAKESHTTA, M. and YONEYAMA, Y., 1977, NADPH-flavin reductase in human erythrocytes and the reduction of methemoglobin through flavin by the enzyme. Biochemical and Biophysical Research Communications, 76, 174–182.
   PubMedGoogle Scholar
• Yumsui, T., MATSUKAWA, S. and YONEYAMA, Y., 1980, Stopped flow studies on the nonenzymatic reduction of methemoglobin by reduced flavin mononucleotide. Journal of Biological Chemistry, 255, 11694–11697.
   Google Scholar